Literature DB >> 31967252

[Coverage and factors associated with measles vaccination in children aged 12-59 months in Peru: estimate based on the 2017 demographic and family health survey].

Karina Vásquez-Uriarte1, Juana Aurelia Ninatanta Ortiz1, Franco Romani2, Joel Christian Roque-Henriquez2,3.   

Abstract

OBJECTIVES: . To estimate coverage and determine factors associated with measles vaccination in Peru.
MATERIALS AND METHODS: . We conducted a secondary source study using the 2017 Demographic and Family Health Survey (ENDES). The reporting unit was a woman of childbearing age, 15 to 49 years; the unit of analysis was a child, 12 to 59 months (for the first dose), or a child, 18 to 59 months (for the booster dose) who had vaccination information. Coverage data were obtained from the vaccination card.
RESULTS: . According to the vaccination card, coverage for the first dose was 70.2% (95% CI: 68.8-71.6); for the booster dose, 52% (95% CI: 50.5-53.6). Children aged 24-35 months were more likely to be vaccinated for the first dose (OR 1.59, 95% CI: 1.28-1.97) and booster dose (OR 2.04, 95% CI: 1.62-2.56), compared with children aged 12-23 months and 18-23 months respectively. Children with growth and development check-ups performed in the private sector were less likely to be vaccinated for the first dose (OR 0.30, 95% CI: 0.21-0.43) and booster dose (OR 0.26, 95% CI: 0.17-0.40), compared to those being monitored in the public sector.
CONCLUSIONS: . According to ENDES 2017, Peru and none of its regions achieved 95.0% coverage for the first and booster doses. Growth and development monitoring in public sector facilities is associated with measles vaccination in terms of first and booster doses.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31967252     DOI: 10.17843/rpmesp.2019.360.4456

Source DB:  PubMed          Journal:  Rev Peru Med Exp Salud Publica        ISSN: 1726-4634


  1 in total

1.  Vaccine Hesitancy: Characteristics of the Refusal of Childhood Vaccination in a Peruvian Population.

Authors:  Kocfa Chung-Delgado; Javier E Valdivia Venero; Tuong M Vu
Journal:  Cureus       Date:  2021-03-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.